PharmD Info

A forum for Indian Pharmacy Professionals

Important: Register today to have the complete access on this forum --- Register Here
Discuss various Doctor of Pharmacy Knowledge based topics
#660
According to results presented at the Heart Failure Society of America Annual Scientific Meeting, dose reduction occurred in 42% of the valsartan/sacubitril group and 43% of the enalapril group during the course of the study. Hypotension was the most cited reason for dose reduction in the valsartan/sacubitril group and cough in the enalapril group. Dose reduction was more common in patients who were older, sicker, had higher levels of serum creatinine and NT-proBNP at baseline, and had an implantable cardioverter defibrillator or cardiac resynchronization therapy device, according to Orly Vardeny, PharmD, MS, from the University of Wisconsin School of Pharmacy.

http://www.healio.com/cardiology/hf-tra ... ower-doses
Similar Topics
Topics Statistics Last post
0 Replies 
573 Views
by rahmatulla.syed
17 Jan 2018, 18:59
Prescription Drug Abuse
by unbreakable  - 02 Feb 2018, 16:11  - In: Drug & Poison Information
0 Replies 
879 Views
by unbreakable
02 Feb 2018, 16:11
Drug Compatibility Chart
by Admin  - 29 Jun 2017, 18:07  - In: Pharmaceutical Care Services
0 Replies 
1439 Views
by Admin
29 Jun 2017, 18:07
FDA - Drug Safety Podcasts
by unbreakable  - 16 May 2018, 14:40  - In: Drug Safety Alerts
0 Replies 
647 Views
by unbreakable
16 May 2018, 14:40
Drug profile Format- Example
by Admin  - 04 Dec 2018, 10:59  - In: Pharm D Topics
0 Replies 
1332 Views
by Admin
04 Dec 2018, 10:59

Tags

We are recruiting faculty members for the departme[…]

Tata Memorial Centre, ACTREC announces PG Diploma […]

Tata Memorial Centre, ACTREC announces One Year Fe[…]

(NIPER JEE) Model Test Papers - Each Question Pape[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES